中国アナボリックステロイドパウダーメーカー
EnglishAfrikaansБългарскиNederlandsFrançaisDeutschItaliano日本語LatīnaNorskپارسیPolskiPortuguêsRomânăРусскийSlovenčinaSlovenščinaEspañolSvenskaTürkçeУкраїнська

局所麻酔薬

» 医薬品 » 局所麻酔薬

  • 仕様
  • 製品説明
  • 製品の使用法
  • COA

化学名: Bupivacaine
MF: C18H28N2O
MW: 288.43
CAS: 2180-92-9
外観: 白い粉
純度: over 99%

Bupivacaine is only found in individuals that have used or taken this drug. It is a widely used local anesthetic agent. [パブケム]Bupivacaine blocks the generation and the conduction of nerve impulses, presumably by increasing the threshold for electrical excitation in the nerve, by slowing the propagation of the nerve impulse, and by reducing the rate of rise of the action potential. Bupivacaine binds to the intracellular portion of sodium channels and blocks sodium influx into nerve cells, which prevents depolarization. In general, the progression of anesthesia is related to the diameter, myelination and conduction velocity of affected nerve fibers. 臨床的に, the order of loss of nerve function is as follows: pain, temperature, touch, proprioception, and skeletal muscle tone. The analgesic effects of Bupivicaine are thought to potentially be due to its binding to the prostaglandin E2 receptors, subtype EP1 (PGE2EP1), which inhibits the production of prostaglandins, thereby reducing fever, 炎症, and hyperalgesia.

Bupivacaine is indicated for local infiltration, peripheral nerve block, sympathetic nerve block, and epidural and caudal blocks. It is sometimes used in combination with epinephrine to prevent systemic absorption and extend the duration of action. The 0.75% (most concentrated) formulation is used in retrobulbar block. It is the most commonly used local anesthetic in epidural anesthesia during labor, as well as in postoperative pain management.Liposomal formulations of buipivacaine are no more effective than plain solutions of bupivacaine.

Bupivacaine is contraindicated in patients with known hypersensitivity reactions to bupivacaine or amino-amide anesthetics. It is also contraindicated in obstetrical paracervical blocks and intravenous regional anaesthesia (Bier block) because of potential risk of tourniquet failure and systemic absorption of the drug and subsequent cardiac arrest. The 0.75% formulation is contraindicated in epidural anesthesia during labor because of the association with refractory cardiac arrest.

分析項目 仕様 結果
外観 White or off white crystalline powder 準拠
溶解性 reely soluble in Dichloromethane, soluble in ethanol, and Ethyl acetate, insoluble in water. 準拠
IdentifIcation そして ;The retention time of the major peak in the choramtogram of the Assay preparation corresponds to that in the 準拠
融点 106℃~110℃ 106.6℃~109.2℃
乾燥減量 ≤ 0.5% 0.03%
any individual impurity not more than 0.3% 0.05%
total impurities not more than 0.5% 0.06%
Limit of residual solvents Conform to standard 準拠
強熱時の残留物 ≤0.1% 0.03%
アッセイ ≥98.5% 99.67%
結論 資格のある

お問い合わせフォーム ( できるだけ早く折り返しご連絡させていただきます )

名前:
*
電子メール:
*
メッセージ:

検証:
2 + 5 = ?

たぶんあなたも好きです

  • 私たちの利点

    良い価格

    高品質

    迅速な配達

    安全な発送

    優れたアフターサービス

  • 地元の倉庫

    EU 倉庫

    英国倉庫

    米国倉庫

    カナダ倉庫

    オーストラリア倉庫

  • 支払方法

    ペイパル

    ビットコイン

    銀行振込

    マネーグラム

    ウエスタンユニオン

  • お問い合わせ

    電子メール: jacob@steroid-peptide.com

    ワッツアップ: +8615636286252

    電話: 0086-15636286252

    Webサイト: www.steroid-peptide.com

    お問い合わせを歓迎します